Even after successful TB treatment, evidence found of lasting lung damage
Despite successful treatment, tuberculosis (TB) can leave lasting and significant damage to the lungs, a new study presented at the ESCMID Global Congress revealed. This damage can manifest as smaller lungs and narrower airways, leading to reduced airflow and impairing quality of life and life expectancy.
Post-TB Lung Damage: A Global Challenge
While antibiotic treatment can effectively cure TB, research on the extent and nature of respiratory damage in survivors remains limited. This study aimed to provide comprehensive insights by analyzing data from 75,631 individuals across 15 studies in 17 countries.
The results were concerning: participants who had previously had TB showed significantly lower lung function across four key measures, with airflow volume being more severely affected than lung capacity. TB survivors also had a 65% higher likelihood of airflow obstruction compared to healthy individuals.
Impact on Quality of Life and Daily Activities
The study’s lead researcher, Dr. Sharenja Ratnakumar of St. George’s, University of London, UK, emphasized the implications for clinical practice and policy. “Our findings strongly suggest that post-tuberculosis lung disease is an under-recognized global challenge,” she explained. “Even when treatment is successful, individuals can be left with significant lung damage, leading to breathlessness that can affect their ability to work and go about their daily lives.
Reducing the burden of post-TB lung damage requires a comprehensive approach, including evidence-based recommendations for diagnosis, treatment, and management. “There is an urgent need for further research to develop effective interventions to mitigate the long-term effects of TB on lung health,” Dr. Ratnakumar concluded.
Key Points:
- TB can have lasting effects on lung structure and function, resulting in smaller lungs and narrower airways.
- TB survivors have significantly lower lung function than healthy individuals, particularly in terms of airflow volume.
- The prevalence of airflow obstruction is 65% higher in TB survivors compared to healthy controls.
- Post-TB lung disease is an under-recognized global challenge with significant implications for quality of life and life expectancy.
- Further research is needed to develop effective interventions to address the long-term effects of TB on lung health.